Covid Vaccine Prompts Strong Immune Response in Younger Children, Pfizer Says

Pfizer Prepares To Seek U.S., EU Approval After Study Shows Vaccine Is Safe For Five To 11-Year-Olds

F.D.A. Decision on Covid Booster Shots Is Expected In Days

A nanoparticle vaccine could provide hope for hard-to-treat prostate cancer